We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+23.98%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$71.2B
AUM Growth
+$9.28B
(+15%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
36.79%
Holding
978
New
47
Increased
453
Reduced
412
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$319M |
| 2 |
Amazon
AMZN
|
+$165M |
| 3 |
Microsoft
MSFT
|
+$110M |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$92.7M |
| 5 |
UnitedHealth
UNH
|
+$69.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$182M |
| 2 |
RTX Corp
RTX
|
+$97.9M |
| 3 |
Marvell Technology
MRVL
|
+$81.2M |
| 4 |
GE Vernova
GEV
|
+$80.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$73.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Healthcare | 12.68% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 10.76% |
| 5 | Financials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Travere Therapeutics
TVTX
$6.15B
| $7.09M | 0.01% |
124,855
-432,292
| -78% | -$19.2M |
|
652
Relay Therapeutics
RLAY
$4.17B
| $6.96M | 0.01% |
+372,169
| New | +$5.4M |
|
653
Coherent
COHR
$55.2B
| $6.95M | 0.01% |
17,625
+1,178
| +7% | +$417K |
|
654
Petrobras
PBR
$130B
| $6.79M | 0.01% |
420,083
-166,252
| -28% | -$3.25M |
|
655
News Corp Class A
NWSA
$16.3B
| $6.79M | 0.01% |
273,322
-7,696
| -3% | -$199K |
|
656
Jack Henry & Associates
JKHY
$11.6B
| $6.76M | 0.01% |
49,073
+1,159
| +2% | +$164K |
|
|
SPTX
657
Seaport Therapeutics
SPTX
$1.33B
| $6.74M | 0.01% |
+310,355
| New | +$5.46M |
|
|
658
Berkshire Hathaway Class A
BRK.A
$1.08T
| $6.74M | 0.01% |
9
-42
| -82% | -$30.3M |
|
659
Patrick Industries
PATK
$2.66B
| $6.73M | 0.01% |
74,963
+18,111
| +32% | +$1.73M |
|
660
Tyson Foods
TSN
$18.1B
| $6.71M | 0.01% |
117,155
-810
| -0.7% | -$50.7K |
|
661
Tandem Diabetes Care
TNDM
$1.38B
| $6.67M | 0.01% |
441,738
+7,711
| +2% | +$135K |
|
662
Immatics
IMTX
$1.46B
| $6.62M | 0.01% |
653,604
-167,113
| -20% | -$1.77M |
|
663
Repligen
RGEN
$9.46B
| $6.6M | 0.01% |
48,404
-22,091
| -31% | -$2.71M |
|
664
Tapestry
TPR
$24.4B
| $6.57M | 0.01% |
44,909
+4,467
| +11% | +$640K |
|
665
Sagimet Biosciences
SGMT
$680M
| $6.55M | 0.01% |
+847,700
| New | +$5.76M |
|
666
HubSpot
HUBS
$12.3B
| $6.53M | 0.01% |
35,765
-5,463
| -13% | -$1.14M |
|
667
CareDx
CDNA
$2.63B
| $6.41M | 0.01% |
224,829
-192,915
| -46% | -$4.2M |
|
668
MP Materials
MP
$9.71B
| $6.35M | 0.01% |
113,406
+12,268
| +12% | +$747K |
|
669
Invesco QQQ Trust
QQQ
$490B
| $6.35M | 0.01% |
8,625
+1,691
| +24% | +$1.16M |
|
|
PCSC
670
DELISTED
Perceptive Capital Solutions
PCSC
| $6.29M | 0.01% |
578,565
| – | – |
|
671
UDR
UDR
$11.7B
| $6.29M | 0.01% |
157,458
+2,590
| +2% | +$95.8K |
|
|
LTC
672
LTC Properties
LTC
$2.22B
| $6.12M | 0.01% |
159,038
-42,121
| -21% | -$1.6M |
|
673
Northrop Grumman
NOC
$73.2B
| $5.99M | 0.01% |
11,770
-51
| -0.4% | -$29.4K |
|
674
Emcor
EME
$33.3B
| $5.98M | 0.01% |
7,209
-995
| -12% | -$842K |
|
675
Futu Holdings
FUTU
$17.1B
| $5.97M | 0.01% |
63,640
+11,125
| +21% | +$1.42M |
|
Similar funds
Aberdeen Group's Q2 2026 Portfolio in Review
As of Q2 2026, Aberdeen Group held 978 positions worth $71.2B, up 15% from $61.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Aberdeen Group's Q2 2026 filing shows 47 new, 453 increased, 412 reduced and 44 closed positions. Its largest new stake was Honeywell Aerospace: 420,093 shares worth $92.9M. The largest sale was Honeywell, an estimated $182M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Aberdeen Group's largest Q2 2026 buy was Honeywell Aerospace: 420,093 shares worth $92.9M.
- Aberdeen Group added most to Tesla in Q2 2026, an estimated $319M increase.
- Aberdeen Group's biggest Q2 2026 reduction was RTX Corp, cutting an estimated $97.9M.
- Aberdeen Group fully exited Honeywell in Q2 2026, selling an estimated $182M.
- Aberdeen Group's ten largest holdings make up 37% of its $71.2B portfolio in Q2 2026.
- Aberdeen Group opened 47 new positions and closed 44 in Q2 2026.
- Aberdeen Group's portfolio value rose 15% quarter-over-quarter to $71.2B.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.